CD40LG and viral hepatitis: The IgM seroprevalence was higher (Q-test, p = 0.006) in patients with confirmed or suspected viral hepatitis (pooled seroprevalence 5.5%, 95% CI: 2.0%– 14.3%) when compared to the other subgroups (pooled seroprevalence 0.9%, 95% CI: 0.6%– 1.5%).